Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand

Nature Medicine

Volumn 4, Issue 11, 1998, Pages 1287-1292

  Miwa, Keiko ^a   Asano, Masahide ^b   Horai, Reiko ^b   Iwakura, Yoichiro ^b   Nagata, Shigekazu ^a,c   Suda, Takashi ^a,d  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; INFLAMMATION; KNOCKOUT MOUSE; MALE; NEUTROPHIL; NONHUMAN; PERITONEUM EXUDATE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASE 1; CELLS, CULTURED; CROSSES, GENETIC; FAS LIGAND PROTEIN; FEMALE; FIBROSARCOMA; HOMOZYGOTE; INFLAMMATION; INTERLEUKIN-1; LYMPHOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN;

ANIMALIA;

EID: 0031730436     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/3276     Document Type: Article

References (43)

1. Suda T., Takahashi, T., Golstein, P. & Nagata, S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75, 1169-1178 (1993).
2. Suda, T. et al. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154, 3806-3813 (1995).
3. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195-200 (1993).
4. Arase, H., Arase, N. & Saito, T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181, 1235-1238 (1995).
5. Suda, T. & Nagata, S. Why do defects in the Fas-Fas ligand system cause autoimmunity? J. Allergy Clin. Immunol. 100, S97-101 (1997).
6. Nagata, S. & Suda, T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39-43 (1995).
7. Barker, C.F. & Billingham, R.E. Immunologically privileged sites. Adv. Immunol. 25, 1-54 (1977).
8. Bellgrau, D. et al. A role for CD95 ligand in preventing graft rejection. Nature 377, 630-632 (1995).
9. Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R. & Ferguson, T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192 (1995).
10. Lau, H.T., Yu, M., Fontana, A. & Stoeckert, C.J. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109-112 (1996).
11. Kang, S.M. et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med. 3, 738-743 (1997).
12. Allison, J., Georgiou, H.M., Strasser, A. & Vaux, D.L. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc. Natl. Acad. Sci. U S A 94, 3943-3947 (1997).
13. O'Connell, J., O'Sullivan, G.C., Collins, J.K. & Shanahan, F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184, 1075-1082 (1996).
14. Hahne, M. et al. Melanoma cell expression of Fas(Apo-1/CD95)ligand: implications for tumor immune escape. Science 274, 1363-1366 (1996).
15. Niehans, G.A. et al. Human lung carcinomas express Fas ligand. Cancer Res. 57, 1007-1012 (1997).
16. Seino, K., Kayagaki, N., Okumura, K. & Yagita, H. Antitumor effect of locally produced CD95 ligand. Nat Med 3, 165-170 (1997).
17. Tanaka, M., Suda T., Takahashi, T. & Nagata, S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135 (1995).
18. Kayagaki, N. et al. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182, 1777-1783 (1995).
19. Mariani, S.M., Matiba, B., Baumler, C. & Krammer, P.H. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25, 2303-2307 (1995).
20. Suda, T., Hashimoto, H., Tanaka, M., Ochi, T. & Nagata, S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J. Exp. Med. 186, 2045-2050 (1997).
21. Tanaka, M., Itai, T., Adachi, M. & Nagata, S. Downregulation of Fas ligand by shedding. Nature Med. 4, 31-36 (1998).
22. Sayers, T.J. et al. Effect of cytokines on polymorphonuclear neutrophil infiltration in the mouse. Prostaglandin-and leukotriene-independent induction of infiltration by IL-1 and tumor necrosis factor. J. Immunol. 141, 1670-1677 (1998).
23. Suda, T., Tanaka, M., Miwa, K. & Nagata, S. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immmol. 157, 3918-3924 (1996).
24. Iwai, K. et al. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84, 1201-1208 (1994).
25. Liles, W.C., Kiener, P.A., Ledbetter, J.A., Aruffo, A. & Klebanoff, S.J. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440 (1996).
26. Li, P. et al. Mice deficient in IL-1 β-converting enzyme are defective in production of mature IL-1 β and resistant to endotoxic shock. Cell 80, 401-411 (1995).
27. Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 β converting enzyme. Science 267, 2000-2003 (1995).
28. Irmler, M. et al. Granzyme A is an interleukin 1 β-converting enzyme. J. Exp. Med. 181, 1917-1922 (1995).
29. Mizutani, H., Schechter, N., Lazarus, G., Black, R.A. & Kupper, T.S. Rapid and specific conversion of precursor interleukin 1 β (IL-1 β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174, 821-825 (1991).
30. Lindemann, A. et al. Granulocyte/macrophage colony-stimulating factor induces interleukin 1 production by human polymorphonuclear neutrophils. J. Immunol. 140, 837-839 (1988).
31. Parsey, M.V., Tuder, R.M. & Abraham, E. Neutrophils are major contributors to intraparenchymal lung IL-1 β expression after hemorrhage and endotoxemia. J. Immunol. 160, 1007-1013 (1998).
32. Hogquist, K.A., Nett, M.A., Unanue, E.R. & Chaplin, D.D. Interleukin 1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA 88, 8485-8489 (1991).
33. Fantuzzi, G. et al. Effect of endotoxin in IL-1 beta-deficient mice. J Immunol. 157, 291-296 (1996).
34. Colotta, F., Re, F., Polentarutti, N., Sozzani, S. & Mantovani, A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80, 2012-2020 (1992).
35. Ghayur, T. et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 386, 619-623 (1997).
36. Kondo, T., Suda, T., Fukuyama, H., Adachi, M. & Nagata, S. Essential roles of the Fas ligand in the development of hepatitis. Nature Med. 3, 409-413 (1997).
37. Nakamoto, Y., Guidotti, L.G., Pasquetto, V., Schreiber, R.D. & Chisari, F.V. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158, 5692-5697 (1997).
38. Giordano, C. et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275, 960-963 (1997).
39. Jaffe, G.J. et al. Expression of interleukin-1 α, interleukin-1 β, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp. Eye Res. 55, 325-335 (1992).
40. de Vos, A.F., Klaren, V.N. & Kijlstra, A. Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat. Invest. Ophthalmol. Vis. Sci. 35, 3873-3883 (1994).
41. Horai, R. et al. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187, 1463-1475 (1998).
42. Mizushima, S. & Nagata, S. pEF-BOS: a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322 (1990).
43. Suda, T. & Nagata, S. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179, 873-878 (1994).